In the Tumor Cancer Genome Analysis (TCGA), CCND1 amplification was observed in 28% of SCCHN, with its frequency reaching 32% in HPV-negative tumors compared to only 6% in those that were HPV-positive. The gene discussed is CCND1; the disease is head and neck squamous cell carcinoma.